Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus‐associated hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Medical Virology

• Publication date

  1994-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jmv.1890420406PMID 8046425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transgenic Mouse Model for Synergistic Effects of Nuclear Oncogenes and Growth Factors in Tumorigenesis: Interaction of c-myc and Transforming Growth Factor α in Hepatic Oncogenesis

  1993cited by this paper
• Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.

  1993cited by this paper
• Splicing mutations of the p53 gene in human hepatocellular carcinoma.

  1993cited by this paper
• Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.

  1993cited by this paper
• Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.

  1993cited by this paper
• p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells.

  1993cited by this paper
• Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses

  1993cited by this paper
• Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.

  1992cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Analysis of the p53 tumor‐suppressor gene in hepatocellular carcinomas from britain

  1992cited by this paper
• Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.

  1992cited by this paper
• Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas.

  1992cited by this paper
• Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates.

  1992cited by this paper
• p53 Mutations in human hepatocellular carcinomas from Germany.

  1992cited by this paper
• Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.

  1992cited by this paper
• Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.

  1992cited by this paper
• Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas.

  1992cited by this paper
• Overexpression of p53: A rare event in a large series of white patients with hepatocellular carcinoma

  1992cited by this paper
• Mutation of p53 gene in hepatocellular carcinoma in Taiwan.

  1992cited by this paper
• Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.

  1992cited by this paper
• Frequent association of p53 gene mutation in invasive bladder cancer.

  1992cited by this paper
• Overexpression and mutation of p53 in endometrial carcinoma.

  1992cited by this paper
• Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions.

  1992cited by this paper
• Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines

  1992cited by this paper
• Transforming growth factor‐alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver

  1992cited by this paper
• Increased expression of transforming growth factor α after transfection of a human hepatoblastoma cell line with the hepatitis B virus

  1992cited by this paper
• Proto-oncogene expression in three human hepatoma cell lines, HCC-M, HCC-T and PLC/PRF/5.

  1991cited by this paper
• p53 mutation in hepatocellular carcinoma after aflatoxin exposure.

  1991cited by this paper
• Hepatocellular carcinoma mutation

  1991cited by this paper
• Negative regulation of human c-fos expression by the retinoblastoma gene product

  1991cited by this paper
• HBx gene of hepatitis B virus induces liver cancer in transgenic mice

  1991cited by this paper
• Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

  1991cited by this paper
• Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

  1991cited by this paper
• Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product.

  1991cited by this paper
• Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

  1991cited by this paper
• Deletions and rearrangements of the retinoblastoma gene in hepatocellular carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors.

  1991cited by this paper
• Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.

  1991cited by this paper
• Point mutation, allelic loss and increased methylation of c‐Ha‐Ras gene in human hepatocellular carcinoma

  1991cited by this paper
• Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.

  1991cited by this paper
• c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas.

  1991cited by this paper
• Regulation of insulin‐like growth factor II Gene expression by hepatitis B virus in hepatocellular carcinoma

  1991cited by this paper
• Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation

  1990cited by this paper
• Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.

  1990cited by this paper
• [Expression of cellular oncogenes in human primary liver cell carcinoma].

  1990cited by this paper
• Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.

  1990cited by this paper
• Hepatitis B virus-associated hepatocellular carcinoma in African patients.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

  1990cited by this paper
• Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

  1990cited by this paper
• Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours

  1990cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast

  1990cited by this paper
• The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.

  1990cited by this paper
• TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas.

  1990cited by this paper
• Basic fibroblast growth factor and transforming growth factor‐α are hepatotrophic mitogens in vitro

  1990cited by this paper
• The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator

  1990cited by this paper
• Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing.

  1990cited by this paper
• Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma

  1990cited by this paper
• Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.

  1989cited by this paper
• The p53 proto-oncogene can act as a suppressor of transformation.

  1989cited by this paper
• Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism.

  1989cited by this paper
• Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats.

  1989cited by this paper
• Low Incidence of Point Mutation of c‐Ki‐ras and N‐ras Oncogenes in Human Hepatocellular Carcinoma

  1989cited by this paper
• Expression of c-myc and N-ras oncogenes in human hepatocellular carcinoma and pancreatic adenocarcinoma. A biochemical and immunocytochemical study.

  1988cited by this paper
• Structural alterations in c-myc and c-Ha-ras proto-oncogenes in human hepatocellular carcinoma.

  1988cited by this paper
• Structural rearrangement of the retinoblastoma gene in human breast carcinoma.

  1988cited by this paper
• Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma

  1988cited by this paper
• Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis.

  1988cited by this paper
• A lack of direct role of hepatitis B virus in the activation of ras and c‐myc oncogenes in human hepatocellular carcinogenesis

  1988cited by this paper
• Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma

  1987cited by this paper
• Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.

  1987cited by this paper
• Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas

  1987cited by this paper
• Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China.

  1987cited by this paper
• Elevation of Transforming Growth Factor α and Its Relationship to the Epidermal Growth Factor and α-Fetoprotein Levels in Patients with Hepatocellular Carcinoma

  1987cited by this paper
• Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.

  1987cited by this paper
• Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.

  1987cited by this paper
• Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17;18 translocation.

  1986cited by this paper
• Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma

  1986cited by this paper
• Base substitution mutations induced by metabolically activated aflatoxin B1.

  1983cited by this paper
• HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS. A Prospective Study of 22 707 Men in Taiwan

  1981cited by this paper
• Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.

  1981cited by this paper
• Role and Mutational Heterogeneity of the p 53 Gene in Hepatocellular Carcinoma I

  year unknowncited by this paper

• Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients

  2021cites this paper
• Epidemiology of Hepatocellular Carcinoma

  2020cites this paper
• Prognostic significance of c-Met, β-catenin and FAK in patients with hepatocellular carcinoma following surgery.

  2018cites this paper
• Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study

  2017cites this paper
• Etiology and Pathogenesis of Hepatocellular Carcinoma: Transcription Factors, Signal Pathways Regulating Proliferation and Apoptosis, and Telomeres/Telomerases

  2017cites this paper
• Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

  2015cites this paper
• Decreased Expression of PTPN12 Correlates with Tumor Recurrence and Poor Survival of Patients with Hepatocellular Carcinoma

  2014cites this paper
• Prognostic Significance of p53, mTOR, c-Met, IGF-1R, and HSP70 Overexpression after the Resection of Hepatocellular Carcinoma

  2014cites this paper
• Rodent Models for Assessing the Role of Stem Cells in Liver Development, Regeneration, and Carcinogenesis

  2013cites this paper
• Comparative immunohistochemical investigation of rat and human hepatocellular carcinomas

  2013cites this paper
• Differential expression of insulin-like growth factor 1 in human primary liver cancer.

  2013cites this paper
• Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.

  2012cites this paper
• Growth factor pathways in development and progression of hepatocellular carcinoma.

  2012cites this paper
• Evaluation of Fbxw7 expression and its correlation with the expression of c‐Myc, cyclin E and p53 in human hepatocellular carcinoma

  2012cites this paper
• Two-stage model of chemically induced hepatocellular carcinoma in mouse.

  2012cites this paper
• Methylation of the UNC5C gene is frequently detected in hepatocellular carcinoma.

  2012cites this paper
• Methylation of the HACE1 gene is frequently detected in hepatocellular carcinoma.

  2012cites this paper
• High Expression of H3K27me3 in Human Hepatocellular Carcinomas Correlates Closely with Vascular Invasion and Predicts Worse Prognosis in Patients

  2011cites this paper
• Interleukin-17F Suppresses Hepatocarcinoma Cell Growth via Inhibition of Tumor Angiogenesis

  2010influential citation
• Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma

  2010cites this paper
• Garcinol inhibits cell growth in hepatocellular carcinoma Hep3B cells through induction of ROS-dependent apoptosis.

  2010cites this paper
• High expression of H 3 K 27 me 3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts patients worse prognosis

  2010cites this paper
• Dual knockdown of N-ras and epiregulin synergistically suppressed the growth of human hepatoma cells.

  2009cites this paper
• Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients

  2009cites this paper
• DIABETES MELLITUS, LIVER DISEASE AND ITS RELATED COMPLICATION OF DIABETES THERAPY- A REVIEW

  2009cites this paper
• c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1.

  2008cites this paper
• Application of Doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma

  2008cites this paper
• Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular Carcinoma

  2007cites this paper
• [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology].

  2007cites this paper
• Antitumor and antiangiogenic activities of anti-vascular endothelial growth factor hairpin ribozyme in human hepatocellular carcinoma cell cultures and xenografts.

  2007cites this paper
• Detection of chromosomal aberrations by comparative genomic hybridization during transformation of human breast epithelial cells in vitro.

  2006cites this paper
• Hepatocellular Carcinoma Humanu-PA Receptor , and Tissue-Type PA Messenger RNAs in Expression of Urokinase-Type Plasminogen Activator ( uPA )

  2006cites this paper
• Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis.

  2006cites this paper
• Is there a role for immunotherapy in hepatocellular carcinoma?

  2006cites this paper
• Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma.

  2005cites this paper
• Molecular mechanisms in hepatocellular carcinoma development.

  2005cites this paper
• Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA-in vitro and in vivo studies

  2005cites this paper
• Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.

  2005cites this paper
• Expression of NGF in hepatocellular carcinoma cells with its receptors in non‐tumor cell components

  2005cites this paper
• Opposite Roles of Human Pancreatitis-Associated Protein and REG1A Expression in Hepatocellular Carcinoma: Association of Pancreatitis-Associated Protein Expression with Low-Stage Hepatocellular Carcinoma, β-Catenin Mutation, and Favorable Prognosis

  2005cites this paper
• Reduction of double‐stranded RNA‐activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus

  2004cites this paper
• cDNA Microarray Analysis in Hepatocyte Differentiation in Huh 7 Cells

  2004cites this paper
• A prospective study of obesity and cancer risk (Sweden)

  2004cites this paper
• cDNA microarray analysis in hepatocyte differentiation in Huh 7 cells.

  2004cites this paper
• Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study

  2004cites this paper
• Relevance of Hepatic Preneoplasia for Human Hepatocarcinogenesis

  2003cites this paper
• The role of HBV and HCV infections in neoplasmatic transformation to hepatocellular carcinoma

  2003cites this paper
• Molekulare Pathogenese des hepatozellulären Karzinoms – Stand 2003

  2003cites this paper
• E2F1 blocks and c-Myc accelerates hepatic ploidy in transgenic mouse models.

  2003cites this paper
• Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.

  2003cites this paper
• Immunohistochemical analysis of p53, cyclin D1,Rb,C-fos and N-ras genes expression in hepatocellular carcinoma in Iran

  2003influential citation
• Beta-catenin mutations in liver tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in CDF1 mice.

  2003cites this paper
• TP53 and liver carcinogenesis

  2003cites this paper
• Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients.

  2002cites this paper
• Transgenic targeting of a dominant negative corepressor to liver and analyses by cDNA microarray.

  2002cites this paper
• The significance of immunohistochemistry in the diagnosis and therapy of neoplasms

  2002cites this paper
• Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP‐ribosyl)ation

  2002cites this paper
• Oncogenes and growth factors

  2002cites this paper
• Cancer Gene Therapy: Past Achievements and Future Challenges

  2002cites this paper
• Animal hepadnaviruses and their host species: Models for human hepatocarcinogenesis

  2002cites this paper
• Brain metastasis from hepatocellular carcinoma associated with hepatitis B virus.

  2002cites this paper
• Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.

  2002cites this paper
• The molecular biology of hepatitis B virus-associated hepatocellular carcinoma

  2002cites this paper
• Immunotherapy of hepatocellular carcinoma

  2002cites this paper
• Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1–24.1

  2001cites this paper
• Transgenic Targeting of a Dominant Negative Corepressor to Liver Blocks Basal Repression by Thyroid Hormone Receptor and Increases Cell Proliferation*

  2001cites this paper
• Expression of c‐Myc, c‐Fos, and c‐Jun in hepatocellular carcinoma

  2001cites this paper
• Hepatocellular Carcinoma: An Update

  2001cites this paper
• The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans

  2001cites this paper
• Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis.

  2001cites this paper
• Tumor cell proliferation of hepatocellular carcinoma, with special reference to ultrasonographic findings and arterial vascularity by US angiography

  2001cites this paper
• HLA class II alleles in Chinese patients with hepatocellular carcinoma.

  2001cites this paper
• Hepatitis B virus in experimental carcinogenesis studies

  2001cites this paper
• Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

  2000cites this paper
• Role of diabetes mellitus in the etiology of hepatocellular carcinoma.

  2000cites this paper
• P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India

  2000cites this paper
• Hepatitis B virus surface (S) transactivator with DNA‐binding properties

  2000cites this paper
• The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas.

  2000cites this paper
• Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues

  2000cites this paper
• Genes and viruses in hepatobiliary neoplasia.

  2000cites this paper
• Treatment for chronic hepatitis B: interferon what we have learned after so many years?

  2000cites this paper
• The role of wild‐type and mutated N‐ras in the malignant transformation of liver cells

  2000cites this paper
• Alterations of P19ARF in rodent hepatoma cell lines but not in human primary liver cancer.

  2000cites this paper
• Gene therapy for liver tumours.

  2000cites this paper
• Overview of Hepatitis B and C Viruses

  2000cites this paper
• Molecular cytogenetic evaluation of virus‐associated and non‐viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias

  2000cites this paper
• p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.

  1999cites this paper
• Amplification of c-myc in Hepatocellular Carcinoma: Correlation with Clinicopathologic Features, Proliferative Activity and p53 Overexpression

  1999cites this paper
• Selective and Nonselective Replication of an E 1 B-deleted Adenovirus in Hepatocellular Carcinoma 1

  1999influential citation
• Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization

  1999cites this paper
• Advances in Brief b-Catenin Mutations Are Frequent in Hepatocellular Carcinomas but Absent in Adenomas Induced by Diethylnitrosamine in B 6 C 3 F 1 Mice 1

  1999cites this paper
• Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice.

  1999cites this paper
• c-fos gene expression in rat liver is induced by phenobarbital.

  1999cites this paper
• p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding

  1999cites this paper
• Mouse Liver Tumorigenesis: Models, Mechanisms, and Relevance to Human Disease

  1999cites this paper
• Hepatitis B virus in hepatocarcinogenesis

  1999cites this paper
• Hepatitis B Virus Infection and Hepatocellular Carcinoma: Molecular Genetics and Clinical Perspectives

  1999cites this paper
• Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma.

  1999cites this paper
• Pathogenesis of hepatitis B and C‐induced hepatocellular carcinoma

  1998cites this paper
• Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines.

  1998cites this paper